ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ALKS Alkermes PLC

24.18
-0.20 (-0.82%)
Last Updated: 17:59:07
Delayed by 15 minutes
Share Name Share Symbol Market Type
Alkermes PLC NASDAQ:ALKS NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.20 -0.82% 24.18 24.18 24.20 24.57 24.11 24.32 421,497 17:59:07

Alkermes to Report First Quarter Financial Results on May 1, 2024

17/04/2024 9:00pm

PR Newswire (US)


Alkermes (NASDAQ:ALKS)
Historical Stock Chart


From Mar 2024 to May 2024

Click Here for more Alkermes Charts.

DUBLIN, April 17, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. BST) on Wednesday, May 1, 2024 to discuss the company's first quarter financial results.

The webcast player and accompanying slides may be accessed on the Investors section of Alkermes' website at www.alkermes.com. The conference call may be accessed by dialing +1 877 407 2988 for U.S. callers and +1 201 389 0923 for international callers. A replay of the webcast will be available approximately two hours after the completion of the event and may be accessed by visiting Alkermes' website. 

About Alkermes plc

Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders. Headquartered in Dublin, Ireland, Alkermes has a research and development center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Alkermes Contact:
Jamie Constantine
Investor Relations
+1 781 873 2402

Alkermes plc Logo

Logo - https://mma.prnewswire.com/media/616416/Alkermes_plc_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/alkermes-to-report-first-quarter-financial-results-on-may-1-2024-302119896.html

Copyright 2024 PR Newswire

1 Year Alkermes Chart

1 Year Alkermes Chart

1 Month Alkermes Chart

1 Month Alkermes Chart

Your Recent History

Delayed Upgrade Clock